Shares of Moderna Inc. were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its...
Shares of Moderna Inc. MRNA were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its COVID-19 vaccine at $110 to $130 per dose. That’s the same price range that Pfizer Inc. PFE and BioNTech BNTX suggested for their COVID vaccine once the COVID vaccines move into a commercial market. They are currently purchased and distributed by the U.S. government. Moderna’s stock is down 13.
... Shares of Moderna Inc. MRNA were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its COVID-19 vaccine at $110 to $130 per dose. That’s the same price range that Pfizer Inc. PFE and BioNTech BNTX suggested for their COVID vaccine once the COVID vaccines move into a commercial market. They are currently purchased and distributed by the U.S. government. Moderna’s stock is down 13.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moderna’s COVID shot to generate $5.0 billion in sales in 2023Shares of Moderna Inc. were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its...
Lire la suite »
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic responseCoronavirus Update: China cracks down on critics of government’s COVID approach
Lire la suite »
The mRNA vaccine technology may hold the key to developing personalized cancer treatmentsAt CES 2023, the CEO of Moderna discusses the development of their COVID-19 vaccine and how to use mRNA technology to create personalized cancer vaccines.
Lire la suite »
Chinese Traveling for Lunar New Year as COVID SurgesWith COVID-19 cases already increasing in China, millions of people are traveling home to visit relatives during the Lunar New Year, which began Saturday.
Lire la suite »
Most people who ended up with long COVID started with a mild case, new study showsThe researchers found 'a staggering' 90% of people living with long COVID only had a mild illness to start \u2014\u00a0but people who were hospitalized were more likely to develop the lasting symptoms.
Lire la suite »